255 related articles for article (PubMed ID: 23936232)
1. Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma.
Bao W; Qiu H; Yang T; Luo X; Zhang H; Wan X
PLoS One; 2013; 8(7):e70616. PubMed ID: 23936232
[TBL] [Abstract][Full Text] [Related]
2. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
3. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis.
Smit MA; Geiger TR; Song JY; Gitelman I; Peeper DS
Mol Cell Biol; 2009 Jul; 29(13):3722-37. PubMed ID: 19414595
[TBL] [Abstract][Full Text] [Related]
4. Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis.
Smit MA; Peeper DS
Oncogene; 2011 Sep; 30(35):3735-44. PubMed ID: 21478908
[TBL] [Abstract][Full Text] [Related]
5. TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.
Kupferman ME; Jiffar T; El-Naggar A; Yilmaz T; Zhou G; Xie T; Feng L; Wang J; Holsinger FC; Yu D; Myers JN
Oncogene; 2010 Apr; 29(14):2047-59. PubMed ID: 20101235
[TBL] [Abstract][Full Text] [Related]
6. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.
Fujikawa H; Tanaka K; Toiyama Y; Saigusa S; Inoue Y; Uchida K; Kusunoki M
J Gastroenterol; 2012 Jul; 47(7):775-84. PubMed ID: 22361863
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer.
Yuan Y; Ye HQ; Ren QC
Int J Oncol; 2018 Feb; 52(2):461-472. PubMed ID: 29345295
[TBL] [Abstract][Full Text] [Related]
8. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN; Cochrane DR; Richer JK
Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
[TBL] [Abstract][Full Text] [Related]
9. ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.
Alonso-Alconada L; Eritja N; Muinelo-Romay L; Barbazan J; Lopez-Lopez R; Matias-Guiu X; Gil-Moreno A; Dolcet X; Abal M
Carcinogenesis; 2014 Dec; 35(12):2679-86. PubMed ID: 25233929
[TBL] [Abstract][Full Text] [Related]
10. A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells.
Bao W; Wang HH; Tian FJ; He XY; Qiu MT; Wang JY; Zhang HJ; Wang LH; Wan XP
Mol Cancer; 2013 Dec; 12():155. PubMed ID: 24321270
[TBL] [Abstract][Full Text] [Related]
11. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
Yuan Y; Ye HQ; Ren QC
Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
[TBL] [Abstract][Full Text] [Related]
14. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
15. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
Howe EN; Cochrane DR; Cittelly DM; Richer JK
PLoS One; 2012; 7(11):e49987. PubMed ID: 23185507
[TBL] [Abstract][Full Text] [Related]
16. TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.
Ricci A; De Vitis C; Noto A; Fattore L; Mariotta S; Cherubini E; Roscilli G; Liguori G; Scognamiglio G; Rocco G; Botti G; Giarnieri E; Giovagnoli MR; De Toma G; Ciliberto G; Mancini R
Cell Cycle; 2013 Jun; 12(11):1696-703. PubMed ID: 23656788
[TBL] [Abstract][Full Text] [Related]
17. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
[TBL] [Abstract][Full Text] [Related]
18. Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer.
Yu X; Liu L; Cai B; He Y; Wan X
Cancer Sci; 2008 Mar; 99(3):543-52. PubMed ID: 18201274
[TBL] [Abstract][Full Text] [Related]
19. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4.
Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127
[TBL] [Abstract][Full Text] [Related]
20. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
